Reply
David Wheeler BS
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorChristine Jelinek BS
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorCarol Anderson BS
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorRebekah Gundry PhD
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorDavid Irani MD, PhD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorPeter Calabresi MD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorRobert Cotter PhD
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorAvindra Nath MD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorDavid Wheeler BS
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorChristine Jelinek BS
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorCarol Anderson BS
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorRebekah Gundry PhD
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorDavid Irani MD, PhD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorPeter Calabresi MD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorRobert Cotter PhD
Department of Pharmacology, Johns Hopkins University, Baltimore, MD
Search for more papers by this authorAvindra Nath MD
Department of Neurology, Johns Hopkins University, Baltimore, MD
Search for more papers by this author
References
- 1 Irani DN, Anderson C, Gundry R, et al. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 2006; 59: 237–247.
- 2 Fainardi E, Castellazzi M, Bellini T, et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler 2006; 12: 294–301.
- 3 Roberts R. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins. Drug News Perspect 2005; 18: 605–614.
- 4 Carrette O, Burkhard PR, Hughes S, et al. Truncated cystatin C in cerebrospiral fluid: technical [corrected] artefact or biological process? Proteomics 2005; 5: 3060–3065.
